Marvin BurnsRadiation Oncology/TherapyNew technology spurs investment in brachytherapyThe U.S. market for brachytherapy products should exceed $1 billion in the next five years, driven by the introduction of new products that allow accelerated treatment for cancer patients after surgery. The worldwide market could grow even more rapidly, according to this analysis from market research firm Bio-Tech Systems.April 22, 2009Nuclear MedicineNew growth for diagnostic radiopharmaceuticalsBased on the number of new products in the pipeline and the amount of venture capital being invested, the future looks promising for radiopharmaceuticals. Current research efforts include novel approaches to imaging myocardial infarction, congestive heart failure, in vivo infection imaging, and new molecular imaging methodologies for oncology.November 8, 2006Nuclear MedicineNew promise for therapeutic radiopharmaceuticalsA surge in research activity is expanding the applications for therapeutic radiopharmaceuticals, which are employing more sophisticated targeting methodologies and more appropriate therapeutic isotopes for the tumors being treated. These new agents will reduce treatment time and accelerate recovery for many patients.June 1, 2006Nuclear MedicineCan SPECT/CT revitalize nuclear medicine?SPECT/CT has been introduced recently with the expectation that it will emulate PET/CT's success as a hybrid imaging modality. Proponents are confident that the addition of CT will provide a new springboard for SPECT in nuclear cardiology as well as other functional studies, revitalizing traditional nuclear medicine.July 6, 2005Page 1 of 1Top StoriesMRIUnstable brain networks may drive multiple sclerosis fatigueFatigue affects between 36.5% and 78% of people with multiple sclerosis and can dramatically impair their daily lives.Womens ImagingAI-calculated BAC on mammograms predicts cardiovascular disease in womenCardiac ImagingECR: Cardiac imaging is at the 'heart' of precision medicineUltrasoundUltrasound MinnieCast, Episode 3: Focused ultrasound brings hope to patientsWomens ImagingECR: LLMs help patients understand breast imaging reports
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
